Clinical Trials Browser

PDAC - Pancreatic Ductal Adenocarcinoma × Gastrointestinal × Clear all

NCT07336953 2026-01-13

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Phase 3 Not yet recruiting

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT07028424 2025-07-01

PANORAMIX

Phase 2 Not yet recruiting

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT06666803 2024-10-31

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

Phase NA Not yet recruiting

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT05853198 2023-05-10

CASPER

Phase NA Recruiting

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT05845801 2023-05-06

PanC-YOUNG

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma